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Abstract
CD4-T-helper-cell (Th) differentiation is influenced by costimulatory molecules expressed on
conventional dendritic cells (DCs) in regional lymph nodes and results in specific patterns of
cytokine production. However, the function of costimulatory molecules on ‘inflammatory’
(CD11b+) DCs in the lung during recall responses is not fully understood, but important for
development of novel interventions to limit immunopathological responses to infection. Using a
mouse model in which vaccination with vaccinia virus vectors expressing the respiratory syncytial
virus (RSV) fusion protein (rVVF) or attachment protein (rVVG) leads to type 1- or type 2-biased
cytokine responses respectively upon RSV-challenge, we found expression of CD40 and OX40L
on lung inflammatory DCs was higher in rVVF- than in rVVG-primed mice early after RSV-
challenge, while the reverse was observed later in the response. Conversely, PD-L2 was higher in
rVVG-primed mice throughout. Inflammatory DCs isolated at the resolution of inflammation
revealed OX40L on type 1-biased DCs promoted IL-5, while on type 2-biased DCs enhanced
IFNγ production by antigen-reactive Th cells. In contrast, PD-L2 promoted IFNγ production
irrespective of conditions, suppressing IL-5 only if expressed on type 1-biased DCs. Thus, OX40L
and PD-L2 expressed on DCs differentially regulate cytokine production during recall responses
in the lung. Manipulation of these costimulatory pathways may provide a novel approach to
controlling pulmonary inflammatory responses.
Introduction
Upon respiratory viral challenge, conventional lung dendritic cells (DCs) mature and
migrate to the regional lymph nodes where they present antigen in the context of MHC to
naïve antigen–specific T cells (1-3). During this period of activation, naïve CD4 T cells are
educated to become T helper (Th)1, Th2, Th17, regulatory T cells (Treg) or remain part of a
large uncommitted population (Th0) that can become polarized at a later stage (4). It now
seems that polarization is reversible, and that both human and mouse Th1 and Th2 cells
maintain flexibility and can respond to alternative polarizing conditions (5-7). These
conditions consist of a combination of cytokines and costimulatory signals typically
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provided by antigen presenting cells (APCs), in particular conventional DCs (5-7). In
models of allergic airway inflammation, DCs have been shown to be required not only to
initiate but also to maintain recall T cell responses (8).
Many costimulatory molecules expressed by DCs have been shown to be important in
regulating T cells during both primary and recall responses. There is evidence that cytokine
production by effector CD4 T cells is solely dependent on DC-derived costimulatory signals
such as CD40 (9). However, naïve and effector T cells differ in the type of costimulation
required for activation/reactivation. For example, CD80 and CD86 are critical for induction
but not reactivation of Th2 cells in an ovalbumin (OVA)-driven mouse model of asthma
(10). In contrast, OX40L is critical for reactivation of Th2 cells in this model (11).
Inflammatory monocytes are recruited to the lung during inflammation where they mature
into CD11b+ (inflammatory) DCs (12). These cells have been shown to increase in numbers
after primary respiratory syncytial virus (RSV) infection, associated with increased CD86
expression, which outlasted viral illness and peak inflammation (13). Recently inflammatory
DCs have been shown to be important in the formation of tertiary lymphoid structures in the
lung and optimal humoral immune responses after viral infection (14). However, the
functional consequences of costimulatory molecule expression on inflammatory DCs for
effector CD4 T cell cytokine production in type 1- and type 2-polarising environments in the
lung have not been studied. In this study we hypothesized that inflammatory DCs provide a
dominant signal in modulating antigen-specific recall responses of CD4 T cells. To address
this hypothesis we used a well characterised mouse model of type 1- and type 2-biased
responses to RSV infection. In this model, the only variable is the antigen used to sensitize
prior to RSV challenge: immunization with recombinant vaccinia virus vectors expressing
the RSV fusion protein (rVVF) or the RSV attachment protein (rVVG) leads to type 1- or
type 2-biased responses respectively during subsequent RSV infection (15-16).
We found that lung DCs matured in type 1- or type 2-biased environments differed
significantly in their expression of CD40, OX40L and PD-L2. These differences were most
pronounced 10 days after RSV challenge, at which time viral replication had passed, airway
cytokine levels had returned to baseline and the disease was resolving. However, DCs
isolated from the lungs at this stage still biased T cell responses according to the
environment from which they came in the absence of detectable IL-12p70 in the immediate
environment. The costimulatory molecule OX40L promoted IFNγ production when
expressed on DCs isolated from a type 2-biased environment and IL-5 when expressed on
DCs isolated from a type 1-biased environment. In contrast, PD-L2 was Th1-enhancing
irrespective of the environment from which the DC came. Our data suggest that OX40L and
PD-L2 expression on DCs, at the time of isolation are functioning to restore the cytokine
balance in the lung. Modulation of these pathways in the airways has the potential to
alleviate viral induced immunopathology.
Materials and Methods
Mice and virus stocks
Eight week-old female BALB/c mice were purchased from Charles River Laboratories, UK.
A DO11.10 mouse colony was established from breeding pairs donated by Professor Claire
Lloyd and bred in-house. All mice were kept in specific pathogen-free conditions. RSV (A2
strain, grown on HEp2 cells following plaque purification); and recombinant vaccinia virus
Western Reserve strain (rVV) expressing the RSV-fusion protein (F) or attachment protein
(G) genes (or β-galactosidase (rVVβgal) as a control) in place of the thymidine kinase (tk)
gene, were grown as previously described (17). All animal work was approved by the Home
Office, London, UK.
Wythe et al. Page 2
J Immunol. Author manuscript; available in PMC 2012 August 15.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Vaccination and RSV-infection
Under anaesthesia with isofluorane, mice were scarified on the rump and 3×106 pfu (in
10μl) rVVF, rVVG, or rVVβ-gal administered. In brief, the rumps of mice were shaved, and
the skin decornified with an emery board. The viral inoculum was adsorbed to the
decornified site, and the mice were observed until fully recovered. Two weeks later, these
mice and naive controls were infected intranasally with 5×105 pfu (in 100μl) RSV or mock
infected with HEp2 lysate, under anaesthesia with isofluorane, as described previously (15).
Mice were weighed and monitored daily thereafter. At various time points post-challenge
mice were culled by overdose of pentobarbitone (3mg, i.p.)
Cell and tissue recovery
Bronchoalveolar lavage (BAL) was performed as described (17) with 1ml of PBS. The BAL
fluid (BALF) retrieved was centrifuged and the supernatant removed and stored at −80°C
prior to analysis. BALF cells were resuspended in PBS/1% BSA /0.1% sodium azide in
preparation for flow-cytometric analysis. Lungs were perfused with PBS via the heart prior
to removal. They were then macerated and enzymatically digested by incubation with 0.1%
collagenase solution for one hour. Cells were washed with PBS and single cell suspensions
obtained by filtration. Red blood cells were lysed with ACK buffer. Live cells were
enumerated by trypan blue exclusion using a haemocytometer.
Flow cytometric analysis of cell surface antigens
BALF, lung and splenic cells were resuspended in PBS/1% BSA /0.1% sodium azide. After
blocking Fc-receptors with anti-CD16/32 antibodies (BD Biosciences, Oxford, UK), surface
stains were performed by incubating cells for 30 mins at 4°C with the appropriate
combinations of the following antibodies and isotype controls: anti-CD11c PE Cy5.5(N418),
Hamster IgG PE Cy5.5(530-6) both from Caltag Laboratories (Burlingame, CA); anti-
MHCII APC(M5/114.15.2), anti-ICOSL PE (HK5.3), anti-OX40L PE (RM134L), anti-PD-
L1 PE (MIH5), anti-PD-L2 PE (122), Rat IgG2b APC (Eb149/10H5) all from ebioscience
(San Diego, CA), and anti-CD40 PE (3/23), anti-CD80 PE (16-10A1), anti-CD86 PE (GL1),
anti-CD11b FITC (M1/70), anti-B220 Cy (RA3-6B2), anti-CD3 Cy (154-2C11), anti-CD4
APC (RM4-5), OX40 FITC (OX-86) [AbD Serotec, Kidlington, UK], anti-CD40L FITC
(MR1) [eBioscience, Hatfield, UK], anti-PD1 PE (J43), anti-MHCII FITC (2G9), Rat
IgG2a κ FITC (R35-95), Rat IgG2b κ FITC (A95-1), Rat IgG2b κ PE (A95-1), Rat IgG2a κ
PE (R35-95), Armenian hamster IgG2 κ PE (B81-3) all from BD Biosciences, unless the
provider is indicated in brackets. Cells were washed and fixed for 15 minutes at 4°C with
4% formalin. Samples were analysed on a Cyan-9 (DAKO) flow cytometer. Eosinophils
were identified as B220−CD3− MHCII−CCR3+ cells that were lymphocytic in size (18).
Generation of antigen-reactive ‘effector’ CD4 T cells with an intermediate Th1/Th2 profile
BALB/c mice were injected intraperitoneally with 0.1μg of OVA peptide (Cambridge
Research Biochemicals, Cambridge UK) adsorbed to alum (100μl) (Perbio Science UK Ltd,
Cramlington, UK). After 7 days, spleens were removed and whole splenocyte populations
were cultured in the presence of 17μg/ml OVA peptide (323-339) (19). CD4 positive cells
were isolated 5 days later by positive immunomagnetic selection as described below.
Cell sorting
CD4 T cells were isolated from the spleens of DO11.10 or BALB/c mice, or from in vitro
splenic cell cultures by first depleting the CD11c+ cells to remove CD4+ antigen presenting
cells (APC). CD4 T cells were then isolated by positive selection with anti-CD4 MACS
beads using an AutoMACS (Miltenyi, Bergisch-Gladbach, Germany). The purity of CD4 T
cell populations was consistently above 90% (>97% when isolated from splenic cell culture)
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(Supplementary Fig.2). DCs were isolated from the lungs of vaccinated BALB/c mice 10
days after RSV-challenge. Single cell suspensions pooled from 16 lungs per group. Fc
receptors were blocked with anti-CD16/32 Abs (Fc block, BD Pharmingen) prior to
enrichment of CD11c+ cells using anti-CD11c MACS beads. Lung DCs were isolated from
CD11c-enriched populations by FACS collecting CD11c+ MHCIIhigh cells. The majority of
these (>70%) expressed CD11b, while only a minority (<16%) expressed the macrophage
marker F4/80. The purity of this population was consistently above 95%. Cell viability was
consistently greater than 95% as assessed by trypan blue exclusion.
DC and alveolar macrophage morphology
Isolated DCs from primed and RSV-challenged mice, and alveolar macrophages from BALF
of naive BALB/c mice were placed into chamber slides (1 × 105 per well) and stimulated
overnight with LPS (10μg/ml) (Sigma-Aldrich Ltd, Dorset, UK) The cells were H&E-
stained and visualised by phase microscopy. Cells were considered to be DCs if they
exhibited dendrite formation (20).
Inflammatory DC co-cultures with naïve DO11.10 and ‘effector’ CD4 T cells by DCs
DCs isolated from lungs of rVVF- or rVVG-primed mice 10 days after RSV-challenge were
pulsed with concentrations of OVA peptide (residues 323-339) ranging from 10-10,000nM
or equivalent concentrations of an irrelevant peptide control (Amyloid Beta 25-35
(Cambridge Research Biochemicals, Cambridge, UK) for 1 hour at 37°C / 5%CO2. CD4 T
cells isolated from spleens of DO11.10 mice or splenic cell cultures (‘effectors’) were added
to DCs at a ratio of 10:1 respectively. Cells were incubated at 37°C/5% CO2 for 96 hours
and concentrations of IFNγ, IL-4,IL-5 and IL-12p70 in culture supernatants determined by
ELISA.
Functional antibody blockade of OX40L and PD-L2 on DCs
DCs isolated from rVVG- or rVVF-primed mice 10 days after RSV-challenge were
incubated with 5μg/ml (determined by prior titration) of functional grade blocking anti-
OX40L (RM134L) or anti-PD-L2 (Ty25) antibodies or the relevant isotype controls,
RatIgG2aκ, and RatIgG2b (ebioscience). Naive or ‘effector’ CD4 T cells were then
cocultured with OVA-peptide-pulsed DCs for 96 hours. Concentrations of IFNγ, IL-4,IL-5
and IL-12p70 in the culture supernatants were determined by ELISA.
Cytokine ELISAs
The concentrations of IFNγ, IL-4 and IL-5 in BALF were determined using the following
paired antibodies: IFNγ; purified (AN-18) and biotinylated (RA-6A2), IL-4; purified
(BVD4-1D11) and biotinylated (BVD6-24G2), IL-5; purified (TRFK5) and biotinylated
(TRFK4) respectively (BD Biosciences, Oxford, UK). TSLP and IL-12p70 levels were
assessed using a DuoSet (R&D Systems, Abingdon, UK). 1) 96 well Maxisorp™ plates
were coated with purified capture antibody (BD: 1:500 in sodium hydrogen carbonate buffer
pH 9.6; R&D: 1:200 in PBS; pH 7.2) and incubated overnight at 4°C; 2) Following a
blocking step with PBS/BSA (1% w/v) (2hrs RT), samples and standards were added in
triplicate and incubated overnight at 4°C; 3) Biotinylated antibodies were diluted as for
primary antibodies, but in PBT diluent [PBS/BSA(1%w/v)/Tween 20 (0.1% v/v)], and
incubated for 1hr at RT; 4) Extravidin-HRP was diluted 1:1000 in PBT diluent, plates
incubated for 30 mins at RT; 5) o-Phenylenediamine dihydrochloride substrate was added
and plates observed for the colorimetric reaction; 6) The reaction was stopped using 1N
H2SO4. Wells were washed in between steps 2-4 with PBS/Tween 20 (0.1% v/v). Optical
density values were determined using a spectrophotometer (Molecular Devices) at 490nm
reference wavelength. Cytokine concentrations were calculated from the standard curves.
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The range for each standard curves were as follows: of IFNγ (4000-8pg/ml), IL-4
(2000-8pg/ml), IL-5 (2000-8pg/ml), IL-12p70 (2500-10pg/ml) and TSLP (1000-8pg/ml).
Statistical analysis
All statistical analysis was performed using GraphPad Prism 5.0 software (GraphPad,
SanDiego, CA, USA). Students t test or Mann Whitney test were used to determine whether
two groups differed significantly from each other for parametric or non-parametric data
respectively. One-way analysis of variance (ANOVA) was used when comparing more than
two groups. If the groups differed significantly a Tukey post-test was applied to determine
where those differences lie. P<0.05 was considered significant.
Results
Memory responses elicit earlier weight loss than primary responses upon RSV challenge
Weight loss is a reliable marker of illness and lung pathology in this model, and is
accelerated by prior sensitizing vaccination (15). After primary infection with RSV, mice
began to lose weight on d5 post infection, with peak weight loss occurring at d8 p.c [Fig.
1(a)]. In comparison, uninfected and mock infected control mice did not lose weight over
the same period of time. In contrast, mice previously vaccinated with rVVF or rVVG began
to lose weight from d1 post RSV challenge (p.c) [Fig.1(b)], and weight loss peaked at d6
p.c, (two days earlier than in primary infection). Mice vaccinated with rVVβGal exhibited
the same kinetic of weight loss upon RSV challenge as during primary infection.
Type 1 and 2 cytokine responses to RSV challenge after rVVF or rVVG priming
To confirm biased cytokine responses in primed mice, we measured the concentrations of
IFNγ , IL-4, IL-5 [Fig.2(a-c)], IL-12p70 and the Th2-inducing epithelial-derived cytokine,
thymic stromal lymphopoietin (TSLP) (21) [Fig.2(d)] in the BALF after RSV challenge. No
IL-12p70 was detected in BALF in any of the groups over the duration of the response (data
not depicted). In mice vaccinated with rVVβGal, IFNγ became detectable on d4, peaked on
d7 and returned to baseline by d10 p.c. IFNγ responses measured in the BALF were
accelerated and enhanced in mice primed with rVVF and rVVG; on d4 and 7 p.c., the
concentration of IFNγ in the BALF was significantly greater in rVVF- than in rVVG-
vaccinated mice (p<0.01) [Fig.2(a)]. By contrast, IL-4, which was detectable in both rVVF
and rVVG, but not in rVVβGal vaccinated mice, was found at, significantly higher levels in
rVVG-vaccinated mice on day 4 p.c. [Fig.2(b)]. Together these findings indicate type 1 bias
after rVVF priming and type 2 bias after rVVG priming. IL-5 was detectable in all three
groups. In rVVF- and rVVβGal IL-5 levels peaked on d7 p.c. at ~75pg/ml in rVVF- and
<50pg/ml in rVVβGal-vaccinated mice. IL-5 levels in rVVG-vaccinated mice peaked earlier
(d4 p.c.) and were significantly increased relative to other groups (~150pg/ml), again
indicating type 2 bias [Fig.2(c)].
BALF TSLP levels were measured at 30-40 pg/ml prior to RSV challenge in all mice,
probably representing basal production from the lung epithelia (22); [Fig.2(d)]. After RSV
infection, TSLP fell steadily in both the rVVβGal and rVVF vaccinated groups to ~10pg/ml
by d10 p.c. However, after an initial decline the concentration of TSLP in the BALF of
rVVG vaccinated mice increased to 50pg/ml on d4 p.c. [Fig.2(d)].
To demonstrate a functional consequence of type 2 bias, eosinophil recruitment to the BALF
was determined by flow cytometry at the peak of inflammation [Fig.2(e-f)]. On d7 p.c,
eosinophils constituted 13% of total BALF cells (23.7±4.8×104cells) in the rVVG-
vaccinated mice compared to less than 3% (4.7±0.7×104cells/ml) and 2% (0.7±0.1×104cells/
ml) respectively in mice primed with rVVF or rVVβGal [Fig.2(e-f)]. This confirmed a
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functional type 2 immune response in rVVG-primed mice that was not detected in the other
groups.
Increases in inflammatory DC numbers following RSV challenge are not affected by type 1-
or type 2-biased environments
To examine whether priming with different antigens caused a change in the magnitude of
the inflammatory DC (MHCIIhiCD11c+CD11b+) response, we enumerated lung
inflammatory DCs during the course of RSV infection. The number of inflammatory DCs
(23) increased ≥8 fold after infection, peaking at 1.2-1.6×106 cells/lung on d7 p.c. [Fig. 3].
Vaccination seemed to slightly delay the peak of DC numbers to d10 p.c. but did not
significantly affect the absolute numbers of DCs at any time point.
DC costimulatory molecule expression differs between type 1- and type 2-biased
environments
We next tested whether inflammatory DCs expressed a different repertoire of costimulatory
molecules in different environments. The percentage of DCs expressing costimulatory
molecules was generally greater in vaccinated compared to mock-vaccinated (rVVβGal)
mice. Prior to RSV challenge, < 30% of DCs expressed the costimulatory molecules
CD80/86, commonly associated with maturation (data not depicted); < 10% expressed CD40
[Fig.4(a)], < 5% OX40L [Fig.4(b)] and < 20% PD-L2 (Fig.4c). In contrast, >40% expressed
ICOSL and >60% expressed PD-L1 (data not depicted). There were no significant
differences in costimulatory molecule expression between the groups prior to RSV infection.
After infection, the percentage of DCs expressing CD80/86 increased to 60%, and those
expressing ICOSL and PD-L1 rose to 70% and 80% respectively by day 10 p.c. There were
no significant differences between rVVF- and rVVG-vaccinated mice (data not depicted).
In contrast, CD40, OX40L, and PDL2 were differentially expressed following RSV
challenge [Fig 4 and Supp Fig.1]. By d2 p.c CD40 expression rose to 36±2.7% of lung DCs
in mice vaccinated with rVVF, significantly more than in the other two groups [Fig.4(a) and
Supp Fig.1]. Expression then dropped to 15.6±1.6% of lung DCs by d7 p.c and remained at
similar levels thereafter. This contrasted with rVVG-vaccinated mice where CD40
expression rose more slowly and reached at 25.0±3.2% on d7 p.c. At this time point there
were significantly more CD40+ DCs in the lungs of rVVG-vaccinated mice (p<0.01) than in
the other groups and this difference was maintained at d30 p.c.
There were similar kinetics of expression for OX40L [Fig.4(b) and Supp Fig.1] peaking on
d2 p.c in rVVF-vaccinated mice followed by deceased expression, and a delayed peak
expression on d10 p.c in rVVG-primed mice. The percentage of OX40L+ DCs also
remained significantly higher in rVVG-vaccinated mice up to d30 p.c. In contrast, the
percentage of PD-L2+ DCs was significantly higher in rVVG-vaccinated mice (p<0.01) at
all time points assessed, peaking on d7 p.c at 70.0±3.4 of lung DCs in rVVG-vaccinated
mice compared with at 40.0±0.4 in rVVF-primed mice [Fig.4(c) and Supp Fig.1].
We also measured the known ligands for these costimulatory molecules; CD40L, OX40 and
PD1 on CD4 T cells in the lung (Supplementary Figure 4). CD40L [Supplementary figure
4(a)] and PD1 [Supplementary figure 4(b)] increased after RSV challenge peaking on day 7
with significantly more CD4 T cells expressing CD40L and PD1 in rVVG-compared to
rVVF-primed mice (p<0.001). However, by day 10 p.c. both CD40L and PD1 were
undetectable. In contrast, OX40 expression peaked on day 10 p.c. in both rVVG- and rVVF-
vaccinated mice and there were no significant differences between the two groups at this
time point [Supplementary figure 4(a)]. Interestingly, on day 30 p.c, CD40L and PD1, but
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not OX40 were again expressed on CD4 T cells with significantly more CD4 T cells
expressing CD40L and PD1 in rVVG- compared to rVVF-primed mice (p<0.001).
Isolated lung DCs from type 1- and type 2-biased environments are viable and induce
biased cytokine responses in naïve and ‘effector’ CD4 T cells
Having shown that the immune environment in which inflammatory DCs mature, programs
them to express a specific repertoire of costimulatory molecules, we investigated whether
these DCs can regulate cytokine production by CD4 T cells. To specifically investigate the
role of DC-expressed costimulatory molecules on CD4 T cells, we isolated viable,
functional inflammatory DCs by sorting MHCIIhi, CD11c+, F4/80lo, CD11b+ cells [Fig.
5(a)]; in these, viability was consistently >95% and sorted cells developed dendrites in
response to LPS stimulation (not seen on alveolar macrophages under the same conditions;
[Fig.5(b)]). Next, we assessed the ability of these DCs pulsed with OVA peptide to bias
naïve and effector CD4 T cells. Naïve OVA-specific CD4 T cells were isolated from the
spleens of DO11.10 mice [>91% pure; Supp Fig.2(a)&(b)]. DCs pulsed with an irrelevant
peptide did not induce any cytokine production by CD4 T cells from DO11.10 mice [Fig.
5(c-e)], but OVA-peptide pulsed DCs from both rVVF- and rVVG-vaccinated mice induced
IFNγ production by DO11.10 T cells. This was significantly increased if DCs were obtained
from rVVF-primed mice [Fig.5(c)]. Conversely, DCs isolated from rVVG-vaccinated mice
induced significantly greater levels of IL-5 [Fig.5(d)]. OVA-peptide pulsed DCs from both
rVVF and rVVG induced IL-4 production from DO11.10 T cells [Fig.5(e)]. Subsequent co-
culture experiments were carried out using an OVA peptide concentration of 10μM.
As inflammatory (CD11b+) DCs have been shown to form close contacts with effector CD4
T cells in organized lymphoid tissue in the lung after viral infection, we asked whether these
DCs can influence cytokine production by non-naïve antigen-reactive cells. Antigen-reactive
CD4 T cells with an intermediate Th1/Th2 profile were generated by culturing whole
splenocyte populations from OVA-sensitized mice in the presence of OVA-peptide (24).
CD4 T cells were then isolated by immunomagnetic separation [>97% pure; Supp Fig.
2(c&d)] and co-cultured with DCs. No cytokine production was detected in the presence of
an irrelevant peptide (data not depicted). With OVA-peptide, IL-12p70 was below the level
of detection (data not depicted), and only low concentrations of IL-4 [<10pg/ml; Fig.5(h)]
could be measured. In contrast, IFNγ [Fig.5(f)] and IL-5 [Fig.5(g)] were detected, with a
trend towards increased IFNγ production when CD4 T cells were co-cultured with rVVF-
DCs, and increased IL-5 levels with rVVG-DC.
OX40 and PD1 are absent on naïve DO11.10 CD4 T cells, but up-regulated on antigen-
activated CD4 T cells
Having shown differential upregulation of OX40L and PD-L2 on inflammatory lung DCs
which cause biased cytokine responses in co-culture with naïve and antigen-activated CD4 T
cells, we then assessed whether their known ligands were expressed on these T cells. Less
than 1% of naïve CD4 T cells expressed OX40 (the true ligand for OX40L) and <2%
expressed PD1 {the only identified ligand for PD-L2 [Supp Fig 3a(ii)]}. In contrast,
approximately 10% of splenic CD4 T cells from OVA sensitized mice expressed OX40 and
2% expressed PD1. Following 5 days of antigen stimulation in vitro, the percentage of CD4
T cells expressing OX40 and PD1, individually or in combination, rose to >40% of the total
CD4 T cell population [Supp Fig 3b(iv)]. In vivo, 10 days post RSV challenge,
approximately 14×104 CD4 T cells in the lung expressed OX40 compared to approximately
3×104 cells at baseline thus confirming the possibility for OX40:OX40L interaction in both
rVVF- and rVVG-primed mice in the lung at this time point. In contrast, PD1 (and CD40L)
peaked at d7p.c. but were absent at d10p.c. (Supplementary figure 4).
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PD-L2 promotes IFNγ production, but OX40L counter-regulates cytokine production by
effector CD4 T cells
Using functional antibody blockade of OX40L and PD-L2 in these co-cultures, we then
investigated how these differentially-expressed costimulatory molecules regulate cytokine
production by CD4 T cells. In cocultures with DO11.10 CD4 T cells, which were stimulated
with a full peptide dose response curve, no significant effects of OX40L- or PD-L2 blockade
on cytokine production were observed (data not depicted). In co-cultures with effector CD4
T cells, blocking OX40L on rVVG-DCs significantly reduced IFNγ production [p<0.05;
Fig.6a(ii)], but had no effect on IL-5 production [Fig.6b(ii)]. Conversely, blocking OX40L
on rVVF-DCs did not affect IFN-γ [Fig.6a(i)], but significantly reduced IL-5 production
[Fig.6b(i)]. In contrast blocking PD-L2 significantly reduced IFNγ concentrations
irrespective of the DCs used to activate effector CD4 T cells [Fig.6c(i-ii)]. It also
significantly enhanced IL-5 levels, but only in co-cultures with rVVF- but not rVVG-DCs
[Fig.6d(i)]. IL-4 levels were not changed by blocking of either costimulatory molecule (data
not depicted).
Discussion
Here we show that CD40, OX40L and PD-L2 expression on lung DCs differ both in timing
and magnitude during type 1- and type 2-biased immune responses to RSV infection and
that these molecules modulate cytokine production by effector but not naïve CD4 T cells.
We confirm the previously reported role for PD-L2 in promoting IFNγ production, but show
for the first time that OX40L counter-regulates ongoing cytokine production by effector
CD4 T cells. This study highlights these two molecules as strong candidates for novel
therapeutic targets to modulate CD4 T cell responses to respiratory pathogens, and
potentially other infectious agents.
It is known that DCs play a critical role in both activation and reactivation of T cells and can
deliver polarizing signals to T cells mediated by cytokines or costimulatory molecules. Of
the costimulatory molecules we investigated, only CD40, OX40L and PD-L2 differed in
their expression between the two environments. Ligation of CD40 has been shown to be
critical for full activation and function of DCs, and has also been closely associated with the
induction of Th1 responses through increasing IL-12p70 production (25-26). Although in
this study CD40 expression was significantly increased in the type 1 environment on day 2
post-challenge, no IL-12p70 could be detected in the airways which may suggest a dominant
role for costimulatory molecules in T cell polarization. In support of this, inflammatory DCs
isolated from type 1-biased environments induced antigen-specific IFNγ responses in both
naïve and effector CD4 T cells without detectable IL-12p70 in the immediate culture
environment. Interestingly, effector T cells produced much less IFNγ than naïve T cells. As
IL-5 levels were comparable, this was not due to the cells being Th2-biased. One possible
explanation is that the reduction in IFNγ occurred due to repeated stimulation of the cells
with peptide, alternatively it could be due to the reduced percentage of antigen-specific CD4
T cells in the effector T cell cocultures (27).
In order to delineate functional roles for OX40L and PD-L2 on lung DCs in viral
inflammation, these molecules were blocked with antibodies during coculture with CD4 T
cells. As CD40 is critical for DC activation, it would not constitute a good therapeutic target,
so we focused on delineating the function of OX40L and PD-L2. Blocking these molecules
had no effect on cytokine production by naïve CD4 T cells. We sought to explain this by
assessing whether they expressed ligands for OX40L and PD-L2. OX40L binds exclusively
to OX40 to exert its functional effects (28). In contrast, while the only identified ligand for
PD-L2 is PD1, PD-L2 has been shown exert T cell stimulatory functions though binding an
as yet unidentified ligand (29-30). We could detect OX40 and PD1 on effector but not naïve
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T cells suggesting the lack of an effect of blocking OX40L and PD-L2 on DCs in cocultures
with naïve CD4 T cells could be attributed to an absence of the ligands for these molecules.
These results suggest that the factors other than those measured in this study are responsible
for the observed bias in cytokine production from naïve CD4 T cells.
In contrast to naïve CD4 T cells, PD-L2 blockade on inflammatory DCs in coculture with
effector CD4 T cells reduced IFNγ production irrespective of the environment from which
the DC came and increased IL-5 production if blocked on DCs from a type 2 environment,
indicating Th1-promoting effects of PD-L2. Our findings support those of other studies that
show PD-L2 is upregulated on DCs in response to Th2 cytokines (31), but serves to down
regulate them. For example, in a model of allergic airway inflammation, adoptive transfer of
DCs activated through PD-L2 into pre-sensitized mice abrogated IL-4 production by T cells
and completely protected the mice from allergic airway inflammation upon allergen
challenge (32). Further, in a mouse model of leishmaniasis, in which host resistance is
associated with Th1 responses and down-regulation of Th2 responses, PD-L2-deficiency
resulted in exacerbated disease and increased parasite burden, indicative of an increased Th2
response (33).
In contrast to PD-L2, blockade of OX40L on DCs from a type 2 environment in co-culture
with effector CD4 T cells reduced the production of IFNγ, while if blocked on DCs from a
type 1 environment OX40L reduced IL-5 production. This may be explained by the findings
that OX40-OX40L interactions can influence the immediate cytokine environment that can
then influence Th differentiation. For example, while OX40 engagement preferentially leads
to generation of Th2 cells which can be driven by autocrine IL-4 and related to enhanced
calcium /NFATc signaling (21, 34-36), in the presence of IL-12 and IFNα, OX40:OX40L
interactions lead to the induction of Th1 responses (21, 37-38). It should also be noted that
reverse signals through OX40L result in the production of pro-inflammatory cytokines
including IL-12, IL-6, IL-1, TNF and IFNα (39-41) from DCs, potentially through
alterations in downstream signaling involving PKCβ2, c-Jun, and c-Fos (42).
We therefore speculate that in our system, modulation of inflammatory DC phenotype in
vivo biases the DC to secrete different cytokines upon OX40L engagement which then
influences the cytokine profile of the T cells following OX40:OX40L interaction. However,
an alternative hypothesis could be that reverse signals from OX40L engagement result in
cytokine secretion into the immunological synapse leading to differences in T cell cytokine
production. Our data show that OX40:OX40L interaction on rVVF-primed DCs is
promoting IL-5 production, while on rVVG-primed DCs it is promoting IFNγ. These data
support our hypothesis that at the time of DC isolation, the DCs are functioning to restore
the cytokine balance in the lung. To our knowledge our study is the first to describe such a
regulatory role for OX40L. Expression of OX40 was also measured on lung CD4 T cells
following RSV challenge. Expression of OX40 peaked on day 10p.c. in both rVVF and
rVVG-primed mice confirming the possibility for OX40:OX40L engagement between CD4
T cells and inflammatory DCs in the lung. However, PD1 was absent at this time. The
absence of PD1 in vivo does not contradict our hypothesis because, as previously
mentioned, PD-L2 is most likely binding another ligand by which it exerts its T cell
stimulatory functions.
Other studies have investigated the role of OX40:OX40L interactions in the induction of
immune responses be they primary or memory (43-45). For example, induction of a primary
Th2 response by TSLP-activated human monocyte-derived DCs was shown to occur in an
OX40L-dependent manner (21). Moreover, in a mouse model of chronic Leishmania major
infection, blocking OX40L on DCs reduced Th2 cytokines and anti-L. major IgG1 and IgE
(46).
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In contrast, in the present study we investigated the role of OX40L expression on DCs after
viral clearance and at the beginning of resolution of pulmonary inflammation when
inflammatory DC numbers were at their greatest. We show that in this phase of the response
to RSV, OX40L expression on inflammatory DCs provides a negative feedback signal
irrespective of the DCs’ cytokine bias. The early expression of OX40L with CD40 on DCs
in type 1 biased responses to RSV, taken together with their delayed expression in type 2
biased responses may indicate that during active viral infection, the function of
inflammatory DCs is to stimulate anti-viral effector T cell functions, which can be
suppressed or delayed by the presence of type 2 cytokines. However, after viral clearance,
the function of these DCs changes from one of activation to one that aids resolution of
inflammation and formation of optimal protective immunological memory. A recent study
has shown that 10 days after viral challenge to the lung, inflammatory DCs are found in
tertiary lymphoid organs (TLOs) in the lung in close contact with effector T and B cells
(14). The interactions between inflammatory DCs and B cells within these TLOs have been
shown to be essential for optimal anti-viral humoral responses. Although the precise
function of inflammatory DCs within TLOs has not been studied, it has been suggested for a
long time that DCs play an important role in terminating T cell responses both directly
through interactions with negative regulators of T cell activation such as PD1 (47) and
CTLA-4, as well as indirectly through induction of regulatory T cell responses (48). Our
data support the hypothesis that the function of DCs and their costimulatory molecules is
time and location dependent.
We therefore speculate that after prior antigenic exposure, and then airway pathogen
challenge, antigen specific memory CD4 T cells are recruited to the lung and interact with
DCs which serve to reactivate their effector function enabling them to secrete a previously
determined cytokine profile. This initial wave of T cell responses biases the cytokine
environment which in turn feeds back onto both resident and recruited inflammatory DCs
resulting in upregulation of a specific repertoire of costimulatory molecules which further
shapes anti-viral T cell responses. Once the virus has been cleared, inflammatory DCs
become essential in the formation of TLOs where they are in close contact with effector T
and B cells in the lung. At this stage we speculate that DC expression of OX40L
(independently of the cytokine environment) and PD-L2 (in a dominant type 2 environment)
are working with effector CD4 T cells to restore the cytokine balance in the lung. This
neutralization of the dominant cytokine profile may inhibit ongoing inflammatory responses
and prevent further cell recruitment, thereby promoting disease resolution.
It has not been previously demonstrated that costimulatory molecules expressed on DCs
isolated from type 1- or type 2-biased environments can influence the cytokine production of
activated naïve and effector CD4 T cells without the addition of polarizing cytokines into
their immediate environment. These novel findings therefore demonstrate the central role of
DC-expressed costimulatory ligands in governing CD4 T cell effector function. Since
effector CD4 T cells exhibit functional plasticity in their ability to produce cytokines (5-7)
our observations support the hypothesis that costimulatory molecules on DCs determine and
modify the quality of T cell cytokine production in ongoing recall responses. This study
highlights a new mechanism by which DCs control effector T cell responses during
established inflammation in the lung. Thus, our study suggests that manipulation of OX40L
and PD-L2 costimulatory pathways has the potential to reduce T-cell-dependent
immunopathology. Such manipulation could provide the basis for novel immunomodulatory
treatments not only for respiratory disease, but also for other inflammatory conditions where
an imbalance of CD4-T-cell-derived cytokines is responsible.
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Figure 1. Memory responses elicit earlier weight loss than primary responses upon RSV
challenge
(a) BALB/c mice were uninfected (control), or challenged intranasally with RSV or Hep2
lysate (Mock infection) or (b) were either unvaccinated and uninfected (Control) or
vaccinated by scarification of the rump with rVVF, rVVG or rVVβGal and challenged with
RSV intranasally 14 days later. All mice were weighed daily after RSV-challenge. These
graphs are representative of 5 independent experiments (n ≥ 5 per group) and show means ±
SD. ANOVA (Tukey post test) result: (a) ***: p<0.001 for RSV versus control and Mock
infected and (b) rVVF and rVVG versus control.
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Figure 2. Type 1- and 2-biased responses to RSV challenge after rVVF or rVVG priming
BALB/c mice were vaccinated with rVVF, rVVG or rVVβGal. 14 days later mice were
challenged with RSV intranasally. At various time points post-challenge mice were
sacrificed and BALF harvested. BALF concentrations of (a) IFN-γ, (b) IL-4, (c) IL-5, and
(d) TSLP were determined by ELISA. (e) BAL eosinophilia was determined by flow
cytometry. Top panel: BALF granulocytes: forward scatter 360-760/B220cy−/CD3cy−,
Lower panel: eosinophils: CD3−B220− MHCII−CCR3+. (f) Eosinophils as percentage of
total BALF cells. The graphs are representative of three independent experiments (n ≥ 5 per
group) and show means ± SD (a-e). ANOVA (Tukey post test) result: rVVF vs rVVG * =
p<0.05, ** = p< 0.01, *** = p<0.001.
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Figure 3. Inflammatory DC number in the lungs is not affected by type 1- or type 2-biased
environments
BALB/c mice were vaccinated by scarification of the rump with rVVF, rVVG or rVVβGal
and challenged with RSV. (a) On days 0, 2, 7, 10 and 30 p.c. mice were sacrificed and the
number of inflammatory DCs in the lung determined. (b) Inflammatory DCs were defined as
CD11c+, MHCIIhi and CD11b+. The graph is representative of two independent
experiments (n ≥ 5 per group) and show means ± SD.
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Figure 4. DC costimulatory molecule expression differs between type 1- and type 2-biased
environments
BALB/c mice were vaccinated by scarification of the rump with rVVF, rVVG or rVVβGal
and challenged with RSV. On days 0, 2, 7, 10 and 30 post challenge mice were sacrificed
and the lungs harvested. The percentage of inflammatory DCs (CD11c+ MHCIIhi CD11b+)
in the lung expressing (a) CD40, (b) OX40L, and (c) PD-L2 were determined by flow
cytometry. Representative dot plots are shown in Supplementary Figure 1. The graphs are
representative of two independent experiments (n ≥ 5 per group) and show means ± SD.
ANOVA (Tukey post test) result: rVVF vs rVVG, ** = p< 0.01, *** = p<0.001).
Wythe et al. Page 18
J Immunol. Author manuscript; available in PMC 2012 August 15.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 5. Isolated lung DCs from type 1- and type 2- biased environments are viable and induce
polarized cytokine responses in naïve and effector CD4 T cells
BALB/c mice were vaccinated by scarification of the rump with rVVF or rVVG and
challenged with RSV. On day 10 post-challenge mice were sacrificed and lungs harvested.
Cells were pooled from the mice within each group and (a) DCs isolated from a CD11c
enriched population by FACS sorting of CD11c+MHCIIhi cells. Top panel: CD11c enriched
cells pre-FACS sorting (left) and post-FACS sorting (right). Lower panel: Expression of
F4/80 on FACS-sorted cells (left) and expression of CD11b on FACS-sorted cells (right).
(b) Isolated lung DCs and macrophages obtained from the BALF of naïve mice were
cultured in the presence of LPS for 24 h and then H&E stained and imaged under phase
microscopy at a magnification of x40. The arrow highlights dendrite formation. Naïve CD4
T cells were isolated from the spleens of DO11.10 mice (Supplementary Figure 2). 1 × 104
DCs per well were pulsed for one hour with increasing concentrations of OVA peptide
(323-339) or an irrelevant peptide control (amyloid beta (residues 25-35) and then
cocultured with 1 × 105 T cells per well for 96 hours. The supernatants were assayed for (c)
IFN-γ, (d) IL-5, and (e) IL-4. 1 × 105 effector CD4 T cells were cocultured with 1 × 104
DCs pulsed with OVA peptide or an irrelevant peptide control (10μM) for 96 hours. The
supernatants were assayed for (f) IFN-γ, (g) IL-5, and (h) IL-4. The graphs are
representative of five independent experiments and show means ± SD (c-e). ANOVA
(Tukey post test) result: OVA peptide –pulsed-rVVF DCs vs –rVVG DCs, * = p < 0.05, **
= p< 0.01, *** = p<0.001).
Wythe et al. Page 19
J Immunol. Author manuscript; available in PMC 2012 August 15.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 6. Cytokine production by effector CD4 T cells is differentially regulated by OX40L and
PD-L2 expression on type 1- and type 2-biased inflammatory DCs
BALB/c mice were vaccinated by scarification of the rump with rVVF or rVVG and
challenged with RSV. On day 10 post-challenge mice were sacrificed and lungs harvested.
Cells were pooled from the mice with in each group and DCs isolated. 1 × 104 DCs per well
from rVVF- (i) or rVVG- (ii) primed mice were pulsed for one hour with 10μM OVA
peptide (323-339) and cocultured with 105 effector CD4 T cells per well for 96 hours in the
presence of anti-OX40L (a, b) or anti-PD-L2 (c, d) or the relevant isotype controls. (a, c)
IFN-γ and (b, d) IL-5 concentrations were determined by ELISA. The graphs are
representative of two independent experiments and show means ± SD. Student t-test result *
= p < 0.05, ** = p<0.01).
Wythe et al. Page 20
J Immunol. Author manuscript; available in PMC 2012 August 15.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
